CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 11,900 shares at an average $4.11 ($48,894)
- 4 Open-market buy Chief Executive Officer bought 18,400 shares at an average $4.36 ($80,228)
- 4 Open-market buy 10% owner bought 18,400 shares at an average $4.36 ($80,228)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 851,546 shares at $3.52 ($2,999,997)
- 4 Open-market buy 10% owner bought 851,546 shares at $3.52 ($2,999,997)
- 4 Open-market buy Director bought 28,384 shares at $3.52 ($99,997)
Page 11 of 18 · 345 filings